APOE and atherosclerosis: The reduction of IP angiogenesis in ApoE−/−PFKFB3ECKO mice, as described in this study, is also in line with previous findings in our group showing decreased IP angiogenesis following administration of the glycolysis inhibitor 3PO in a mouse model of advanced atherosclerosis [19].